Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-170 |
Sentence |
denotes |
From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. |
T1 |
0-170 |
Sentence |
denotes |
From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. |
TextSentencer_T2 |
171-268 |
Sentence |
denotes |
Overexpression of the HER2/Neu protooncogene has been linked to the progression of breast cancer. |
T2 |
171-268 |
Sentence |
denotes |
Overexpression of the HER2/Neu protooncogene has been linked to the progression of breast cancer. |
TextSentencer_T3 |
269-397 |
Sentence |
denotes |
Here we demonstrate that the growth of prostate cancer LNCaP cells can also be increased by the stable transfection of HER2/Neu. |
T3 |
269-397 |
Sentence |
denotes |
Here we demonstrate that the growth of prostate cancer LNCaP cells can also be increased by the stable transfection of HER2/Neu. |
TextSentencer_T4 |
398-715 |
Sentence |
denotes |
Using AG879, a HER2/Neu inhibitor, and PD98059, a MAP kinase inhibitor, as well as MAP kinase phosphatase-1 (MPK-1), in the transfection assay, we found that HER2/Neu could induce prostate-specific antigen (PSA), a marker for the progression of prostate cancer, through the MAP kinase pathway at a low androgen level. |
T4 |
398-715 |
Sentence |
denotes |
Using AG879, a HER2/Neu inhibitor, and PD98059, a MAP kinase inhibitor, as well as MAP kinase phosphatase-1 (MPK-1), in the transfection assay, we found that HER2/Neu could induce prostate-specific antigen (PSA), a marker for the progression of prostate cancer, through the MAP kinase pathway at a low androgen level. |
TextSentencer_T5 |
716-937 |
Sentence |
denotes |
Reporter assays and mammalian two-hybrid assays further suggest this HER2/Neu-induced androgen receptor (AR) transactivation may function through the promotion of interaction between AR and AR coactivators, such as ARA70. |
T5 |
716-937 |
Sentence |
denotes |
Reporter assays and mammalian two-hybrid assays further suggest this HER2/Neu-induced androgen receptor (AR) transactivation may function through the promotion of interaction between AR and AR coactivators, such as ARA70. |
TextSentencer_T6 |
938-1127 |
Sentence |
denotes |
Furthermore, we found this HER2/Neu --> MAP kinase --> AR-ARAs --> PSA pathway could not be blocked completely by hydroxyflutamide, an antiandrogen used in the treatment of prostate cancer. |
T6 |
938-1127 |
Sentence |
denotes |
Furthermore, we found this HER2/Neu --> MAP kinase --> AR-ARAs --> PSA pathway could not be blocked completely by hydroxyflutamide, an antiandrogen used in the treatment of prostate cancer. |
TextSentencer_T7 |
1128-1361 |
Sentence |
denotes |
Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients. |
T7 |
1128-1361 |
Sentence |
denotes |
Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients. |